- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02288715
Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated Encephalopathy
October 31, 2017 updated by: Kang Yan
The purpose of the study is to evaluate whether variability of CPP (cerebral perfusion pressure) is related to sepsis-associated encephalopathy and outcomes of patients with sepsis.
Study Overview
Detailed Description
Encephalopathy is a common complication of sepsis, impaired cerebrovascular autoregulation (AR) in patients with sepsis is considered related to Sepsis-associated encephalopathy (SAE).
As AR is important in stabilizing the cerebral perfusion pressure, whether greater variability of CPP is related to SAE and mortality or not remains unclear.
We conduct this study to evaluate the relationship between them.
Study Type
Observational
Enrollment (Actual)
110
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- Kang Yan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
all patients admit to the general ICU of an academic teaching hospital
Description
Inclusion Criteria:
- clinical symptoms of sepsis, severe sepsis and septic shock
- age over 18 years
Exclusion Criteria:
- preexisting Neurological diseases
- traumatic brain injury
- intracranial infectious disease
- severe hepatic or renal dysfunction
- ICU discharge Within 72 hours
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
SAE
patient who develop encephalopathy in the progress of sepsis
|
|
|
non-SAE
patient who do not develop encephalopathy in the progress of sepsis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
relationship between cerebral perfusion pressure variability and sepsis-associated encephalopathy
Time Frame: cerebral perfusion pressure is assessed up to 72 hours
|
To estimate CPP noninvasively, we will monitor the middle cerebral artery flow velocity of patients with sepsis using transcranial Doppler ultrasound in the first 72h of their enrollment.
Diagnosis of a SAE was performed using the confusion assessment method for ICU(CAM-ICU).
|
cerebral perfusion pressure is assessed up to 72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of mechanical ventilation
Time Frame: All the participants will be followed up until discharge or death, assessed up to 24 months
|
All the participants will be followed up until discharge or death, assessed up to 24 months
|
|
|
Time of ICU stay
Time Frame: All the participants will be followed up until discharge or death, assessed up to 24 months
|
All the participants will be followed up until discharge or death, assessed up to 24 months
|
|
|
Time of hospital stay
Time Frame: All the participants will be followed up until discharge or death, assessed up to 24 months
|
All the participants will be followed up until discharge or death, assessed up to 24 months
|
|
|
90-day mortality rate
Time Frame: All the participants will be followed up until 90 days after their enrollment or death
|
All the participants will be followed up until 90 days after their enrollment or death
|
|
|
1-year mortality rate
Time Frame: All the participants will be followed up until 1 year after their enrollment or death
|
All the participants will be followed up until 1 year after their enrollment or death
|
|
|
2-year mortality rate
Time Frame: All the participants will be followed up until 2 years after their enrollment or death
|
All the participants will be followed up until 2 years after their enrollment or death
|
|
|
1-year quality of life of survivors
Time Frame: All the participants will be followed up until 1 year after their enrollment or death
|
EQ-5D will be used to evaluate quality of life of survivors
|
All the participants will be followed up until 1 year after their enrollment or death
|
|
2-year quality of life of survivors
Time Frame: All the participants will be followed up until 2 year after their enrollment or death
|
EQ-5D will be used to evaluate quality of life of survivors
|
All the participants will be followed up until 2 year after their enrollment or death
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2014
Primary Completion (Actual)
March 1, 2015
Study Completion (Actual)
March 1, 2017
Study Registration Dates
First Submitted
October 27, 2014
First Submitted That Met QC Criteria
November 6, 2014
First Posted (Estimate)
November 11, 2014
Study Record Updates
Last Update Posted (Actual)
November 6, 2017
Last Update Submitted That Met QC Criteria
October 31, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPPV-KYan1205
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
Clinical Trials on no interventions
-
National Taiwan University HospitalNot yet recruitingThe Cardiac Function
-
Chinese University of Hong KongRecruiting
-
Royal Brompton & Harefield NHS Foundation TrustRecruitingIdiopathic Pulmonary Fibrosis (IPF) | Progressive Pulmonary FibrosisUnited Kingdom
-
University of IoanninaEnrolling by invitationCarpal Tunnel Syndrome (CTS)Greece
-
Marmara UniversityCompleted
-
Fudan UniversityRecruiting
-
Karolinska InstitutetKarolinska University HospitalRecruitingStroke | Aging | Neuro-Degenerative Disease | Gait Impairment in Stroke PatientsSweden
-
Tianjin Medical University General HospitalRecruitingNeonatal Diabetes | Monogenic Diabetes | Maturity Onset Diabetes of the YoungChina
-
Masarykova Nemocnice v Usti nad Labem, Krajska...Not yet recruitingPost Thrombotic Syndrome | Catheter Thrombosis | Pulmonary Embolism (Diagnosis)
-
Ehab A. AbdallahHorus UniversityNot yet recruitingGrip Strength | Hand Joint HypermobilityEgypt